First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors Article

Full Text via DOI: 10.1200/JCO.2025.43.4_suppl.606 Web of Science: 001423524800011

Cited authors

  • Mizrahi J, Senapedis W, O'Donnell C, Hodgson JG, Newman JV, Siecinski S, Lin CC

Authors

Publication date

  • 2025

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Number of pages

  • 1

Start page

  • 606

End page

  • 606

Volume

  • 43

Issue

  • 4_SUPPL